Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Clinical Trial 37878

East Windsor, NJ 08520


Study Summary:

A randomized, double-blind, placebo-controoled, parallel-group, multicenter study to explore changes in subcutaneous adipose tissue and modulation of skin inflammation after 12 weeks of treatment with secukinumab, compared to placebo, and up to 52 weeks of treatment with secukinumab in abult patients with moderate to severe plaque psoriasis.


Qualified Participants Must:

• Be 18 years or older and have at least 10% body surface area of psoriasis


Qualified Participants May Receive:

Study medication and visits at no cost as well as compensation for their time and travel.


Research Site Profile

View Clinic Profile


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.